These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 15340093
1. Injection of recombinant FcalphaRI/CD89 in mice does not induce mesangial IgA deposition. van der Boog PJ, van Kooten C, van Zandbergen G, Klar-Mohamad N, Oortwijn B, Bos NA, van Remoortere A, Hokke CH, de Fijter JW, Daha MR. Nephrol Dial Transplant; 2004 Nov; 19(11):2729-36. PubMed ID: 15340093 [Abstract] [Full Text] [Related]
2. Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy. van der Boog PJ, De Fijter JW, Van Kooten C, Van Der Holst R, Van Seggelen A, Van Es LA, Daha MR. Kidney Int; 2003 Feb; 63(2):514-21. PubMed ID: 12631116 [Abstract] [Full Text] [Related]
3. Monomeric and polymeric IgA show a similar association with the myeloid FcalphaRI/CD89. Oortwijn BD, Roos A, van der Boog PJ, Klar-Mohamad N, van Remoortere A, Deelder AM, Daha MR, van Kooten C. Mol Immunol; 2007 Feb; 44(5):966-73. PubMed ID: 16675016 [Abstract] [Full Text] [Related]
4. The glomerular response to IgA deposition in IgA nephropathy. Moura IC, Benhamou M, Launay P, Vrtovsnik F, Blank U, Monteiro RC. Semin Nephrol; 2008 Jan; 28(1):88-95. PubMed ID: 18222350 [Abstract] [Full Text] [Related]
7. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. Launay P, Grossetête B, Arcos-Fajardo M, Gaudin E, Torres SP, Beaudoin L, Patey-Mariaud de Serre N, Lehuen A, Monteiro RC. J Exp Med; 2000 Jun 05; 191(11):1999-2009. PubMed ID: 10839814 [Abstract] [Full Text] [Related]
8. Pathogenic significance of IgA receptor interactions in IgA nephropathy. Monteiro RC, Moura IC, Launay P, Tsuge T, Haddad E, Benhamou M, Cooper MD, Arcos-Fajardo M. Trends Mol Med; 2002 Oct 05; 8(10):464-8. PubMed ID: 12383768 [Abstract] [Full Text] [Related]
9. Role of IgA receptors in the pathogenesis of IgA nephropathy. Lechner SM, Papista C, Chemouny JM, Berthelot L, Monteiro RC. J Nephrol; 2016 Feb 05; 29(1):5-11. PubMed ID: 26572664 [Abstract] [Full Text] [Related]
10. Expression of Fc alpha/mu receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy. McDonald KJ, Cameron AJ, Allen JM, Jardine AG. Biochem Biophys Res Commun; 2002 Jan 11; 290(1):438-42. PubMed ID: 11779189 [Abstract] [Full Text] [Related]
11. IgA-CD89 complex in IgA nephropathy: a study on molecular function. Wiwanitkit V. Ren Fail; 2006 Jan 11; 28(6):457-9. PubMed ID: 16928613 [Abstract] [Full Text] [Related]
12. Size-dependent effect of IgA on the IgA Fc receptor (CD89). Reterink TJ, van Zandbergen G, van Egmond M, Klar-Mohamad N, Morton CH, van de Winkel JG, Daha MR. Eur J Immunol; 1997 Sep 11; 27(9):2219-24. PubMed ID: 9341762 [Abstract] [Full Text] [Related]
13. Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation. Wehbi B, Oblet C, Boyer F, Huard A, Druilhe A, Paraf F, Cogné E, Moreau J, El Makhour Y, Badran B, Van Egmond M, Cogné M, Aldigier JC. J Am Soc Nephrol; 2019 Jul 11; 30(7):1238-1249. PubMed ID: 31227634 [Abstract] [Full Text] [Related]
14. Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor. Kanamaru Y, Arcos-Fajardo M, Moura IC, Tsuge T, Cohen H, Essig M, Vrtovsnik F, Loirat C, Peuchmaur M, Beaudoin L, Launay P, Lehuen A, Blank U, Monteiro RC. Eur J Immunol; 2007 Apr 11; 37(4):1116-28. PubMed ID: 17393381 [Abstract] [Full Text] [Related]
15. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy. Xu L, Li B, Huang M, Xie K, Li D, Li Y, Gu H, Fang J. PLoS One; 2016 Apr 11; 11(7):e0159426. PubMed ID: 27437939 [Abstract] [Full Text] [Related]
16. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy. Cambier A, Gleeson PJ, Abbad L, Canesi F, da Silva J, Bex-Coudrat J, Deschênes G, Boyer O, Rabant M, Ulinski T, Hogan J, Peuchmaur M, Berthelot L, Monteiro RC. Kidney Int; 2022 Feb 11; 101(2):274-287. PubMed ID: 34756952 [Abstract] [Full Text] [Related]
17. IgA induced activation of human mesangial cells: independent of FcalphaR1 (CD 89). Diven SC, Caflisch CR, Hammond DK, Weigel PH, Oka JA, Goldblum RM. Kidney Int; 1998 Sep 11; 54(3):837-47. PubMed ID: 9734608 [Abstract] [Full Text] [Related]
18. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy. Leung JC, Chan LY, Tsang AW, Liu EW, Lam MF, Tang SC, Lai KN. Nephrol Dial Transplant; 2004 Aug 11; 19(8):1976-85. PubMed ID: 15187193 [Abstract] [Full Text] [Related]
19. Size-dependent binding of IgA to HepG2, U937, and human mesangial cells. Leung JC, Tsang AW, Chan LY, Tang SC, Lam MF, Lai KN. J Lab Clin Med; 2002 Dec 11; 140(6):398-406. PubMed ID: 12486407 [Abstract] [Full Text] [Related]
20. Human mesangial cells in culture and in kidney sections fail to express Fc alpha receptor (CD89). Westerhuis R, Van Zandbergen G, Verhagen NA, Klar-Mohamad N, Daha MR, van Kooten C. J Am Soc Nephrol; 1999 Apr 11; 10(4):770-8. PubMed ID: 10203361 [Abstract] [Full Text] [Related] Page: [Next] [New Search]